Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof
TW202629264APending Publication Date: 2026-07-16IMMUNOGEN INC
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- IMMUNOGEN INC
- Filing Date
- 2018-02-27
- Publication Date
- 2026-07-16
Abstract
The invention relates to novel cell-binding agent-maytansinoid conjugate having a self-immolative peptide linker and more specifically to conjugates of formula (I). The invention also provides novel maytansinoid compounds of formula (II), (III), (IV) or (V). The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention.
Need to check novelty before this filing date? Find Prior Art